Identity
Measure biological starting conditions instead of assuming that a strain label captures every relevant difference.
Early-stage research programme
Biological identity, made measurable.
SIBYL is a rodent-first project exploring how reproductive biology, controlled developmental environments, simulation and genomic quality control could enable more traceable and reproducible laboratory animal lineages.
The problem
“Standardized” does not mean fully traceable.
Laboratory animals can differ through genetic drift, de novo mutations, epigenetic state, microbiome, housing, diet, handling, age and developmental history. SIBYL asks whether laboratories can preserve and verify a biological reference lineage more accurately than present breeding and cloning methods allow.
Development
Treat developmental environment and lineage history as part of the experimental system, not invisible background.
Reproducibility
Create stable reference baselines against which deliberate biological variation can be tested across sites and time.
The approach
A wet-lab goal with an engineering control layer.
Simulation and AI are used to narrow assumptions and monitor quality; they do not replace the biological programme. Each stage must produce evidence before the next, more expensive stage begins.
Map failure modes
Build a reviewed architecture, literature map, simulation specification and risk register.
Prototype controls
Test sensing, imaging, environmental stability and closed-loop operation without reproductive experiments.
Partner-lab study
Test one narrow biological subsystem through a qualified laboratory with appropriate oversight.
Demand replication
Compare experiment with simulation, repeat the result and obtain independent technical review.
Roadmap
The first 24 months.
The first programme is designed to convert an informed hypothesis into a credible experimental platform. It is not presented as sufficient to complete indefinite cloning.
Months 0–3
Architecture gate
Technical architecture, literature map, failure-mode register, ethics route, simulation specification and external review.
Months 2–7
Physical-control gate
Benchtop sensing, imaging and environmental-control prototype demonstrating stable closed-loop operation.
Months 6–15
Biological-validation gate
Formal partner-laboratory collaboration and one predefined biological subsystem test with an animal-welfare plan.
Months 12–24
Replication gate
Repeatability data, independent review, comparison against simulation and preparation for a larger wet-lab financing round.
Team
Veterinary, biological and computational perspectives.
SIBYL is being developed by an informal early-stage team. Roles below describe intended responsibilities; no claim is made that a complete laboratory organisation or validated platform already exists.
Razin R. K.
Veterinary medicine, animal-model direction, welfare, clinical relevance and domain collaboration.
S. W.
Biotechnology, simulation, AI/ML systems, architecture and engineering integration.
S. D.
Neuroscience and optogenetics perspective, with experience relevant to rodent experimental work.
Scientific boundaries
Ambitious, but explicit about what is not yet proven.
- SIBYL has not produced a cloned animal or validated biological prototype.
- Existing research supports individual components and partial transitions, not a complete repeatable pipeline.
- Initial biological work is non-human and rodent-first.
- Animal experiments would occur only through qualified partner laboratories with appropriate ethics and welfare review.
- Human reproductive use is not an initial objective.
This website describes an early research direction and intended programme. It does not advertise a medical product, a completed cloning method, or demonstrated biological outcomes.